The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma

Clinics in Liver Disease

Volumn 5, Issue 1, 2001, Pages 145-159

  Johnson, Philip J ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; FLUOROURACIL; INTERFERON;

AMINO ACID SEQUENCE; CANCER DIAGNOSIS; CANCER SIZE; CHRONIC LIVER DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DRUG RESPONSE; HUMAN; LIVER CELL CARCINOMA; QUANTITATIVE ASSAY; REFERENCE VALUE; REVIEW; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 0035143887     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(05)70158-6     Document Type: Article

References (63)

1. Production of embryonal α-globulin by transplantable mouse hepatomas
2. Human α-fetoprotein: Isolation, characterization, and demonstration of microheterogeneity
3. Alpha-fetoprotein (AFP) in benign liver disease: Evidence that normal liver regeneration does not induce AFP synthesis
4. Alpha-fetoprotein in human hepatoma: Improved detection in serum and quantitative studies using a new sensitive technique
5. Role of serum alpha-fetoprotein in pre- and post-orthotopic liver transplantation (OLT) for malignant disease
6. Fucosylated alphafetoprotein as a marker of early hepatocellular carcinoma
7. Differential reactivity of alpha-fetoprotein with lectins and evaluation of its usefulness in the diagnosis of hepatocellular carcinoma
8. Intra-arterial chemotherapy using an implantable infusion pump and liver irradiation for treatment of hepatic metastases
9. New albumin gene 3′ adjacent to the alpha 1-fetoprotein locus
10. Demonstration of new protein fraction in serum from the human fetus
11. Serum alpha-fetoprotein levels in patients with non-neoplastic liver diseases
12. Alpha-fetoprotein in nonneoplastic hepatic disorders
13. Lentil lectin-reactive alphafetoprotein in the differential diagnosis of benign and malignant liver disease
14. Detection of hepatocellular carcinoma-specific alpha-fetoprotein by isoelectric focusing
15. Radioimmunoassay of alpha-fetoprotein in human plasma
16. Second-look laparotomy in endodermal sinus tumour: A report of two patients with normal levels of alpha-fetoprotein and residual tumour at re-exploration
17. Differential alpha-fetoprotein lectin binding in hepatocellular carcinoma
18. Elevation of alphafetoprotein level without evidence of recurrence after hepatectomy for hepatocellular carcinoma
19. Human α-fetoprotein produced from Hep G2 cell line: Structure and heterogeneity of the oligosaccharide moiety
20. The role of biologic tumour markers in testicular cancer
21. Germ cell tumours express a specific alpha-fetoprotein variant detectable by isoelectric focusing
22. 'Hepatoma-specific=' alphafetoprotein may permit preclinical diagnosis of malignant change in patients with chronic liver disease
23. Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour
24. Alpha-fetoprotein concentration measured by radioimmunoassay in the diagnosing and excluding of hepatocellular carcinoma
25. Serum alpha-fetoprotein estimations and doubling time in hepatocellular carcinoma: Influence of therapy and possible value in early detection
26. Induction of remission in hepatocellular carcinoma with doxorubicin
27. Biopsy diagnosis of well-differentiated hepatocellular carcinoma based on new morphologic criteria
28. Positive alpha-fetoprotein in a case of gastric carcinoma
29. Serum AFP and HCG in the treatment of patient with testicular tumours
30. 90 microspheres
31. Specificity of serum α-fetoprotein in HBsAg+ and HBsAg-patients in the diagnosis of hepatocellular carcinoma
32. Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma
33. Alpha-fetoprotein changes in the course of chronic hepatitis: Relation to bridging hepatic necrosis and hepatocellular carcinoma
34. Alpha-fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: Role in the early detection of hepatocellular carcinoma
35. Occurrence of fetoprotein in patients with neoplasms and nonneoplastic diseases
36. Radioimmunoassay of α-fetoprotein: I. Technique and serum level in normal adult
37. Influence of age on alphafetoprotein incidence
38. Effect of surgical and chemotherapeutic treatment on alpha-fetoprotein levels in patients with hepatocellular carcinoma
39. Serum a-fetoprotein in patients with neoplasms of the GI tract
40. Serum alphafetoglobulin with gastric and prostatic carcinomas
41. Hepatocellular carcinoma in the non-cirrhotic liver: A comparison with that complicating cirrhosis
42. Age-related, different clinicopathologic features of hepatocellular carcinoma patients
43. Intraoperative single-dose radiotherapy. Observations on staging and interstitial treatment of unresectable liver metastases
44. A collaborative study for the evaluation of a serological test for primary cancer
45. Studies of carcino-fetal protein III. Development of a radioimmunoassay of alpha-fetoprotein. Demonstration of alpha-fetoprotein in serum of healthy human adults
46. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein
47. Serological tumour markers in hepatocellular carcinoma
48. Diagnostic application of alpha-fetoprotein, government regulations prevent full application of a clinically useful test
49. Cancer markers of the 1990's
50. Comparison of carbohydrate structures for serum α-fetoprotein by sequential glycosidase digestion and lectin affinity electrophoresis
51. The detection of alpha 1-fetoprotein in patients with viral hepatitis
52. Embryonic antigens in liver tumors in rats
53. Alpha-fetoprotein
54. Alpha-fetoprotein in the 1990s
55. A collaborative study for the elevation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma
56. Distinct molecular species of human alpha-fetoprotein due to differential affinities to lectins
57. Human alpha-fetoprotein. Molecular weight data from electrospray mass spectrometry (ESMS) analysis
58. Presence of embryospecific α-globulin in the serum of patients with primary hepatocellular carcinoma
59. Primary cancer in Japan. Sixth report
60. Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients
61. An assessment of therapeutic effect of hepatocellular carcinoma by the serial change of serum AFP value
62. Sugar chains of human cord serum α-fetoprotein: Characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas
63. Structure of the asparagine-linked sugar chains of α-fetoprotein purified from human ascites fluid